Lung Cancer - Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Lymphoma - Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
Non-Hodgkin Lymphoma - Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Obsessive-Compulsive Disorder - FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder LEF
Osteoporosis - Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Palomar Medical Technologies Inc - Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
Patents - U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
Perrigo Company - Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Regulatory Actions - Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
Regulatory Actions - Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
Regulatory Actions - Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
RNA Research - AVI BioPharma Announces Commencement of Dosing in Clinical Trial for Duchenne Muscular Dystrophy
Three Palm Software - Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
XTENT, Inc. - XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe